Published in J Histochem Cytochem on May 04, 2012
Rab27A regulates transport of cell surface receptors modulating multinucleation and lysosome-related organelles in osteoclasts. Sci Rep (2015) 0.79
Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis. PLoS One (2015) 0.76
Novel interaction of Rab13 and Rab8 with endospanins. FEBS Open Bio (2013) 0.75
The Roles of Small GTPases in Osteoclast Biology. Orthop Muscular Syst (2015) 0.75
Molecular characterization of human osteoblast-derived extracellular vesicle mRNA using next-generation sequencing. Biochim Biophys Acta (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol (2009) 13.01
Rabs and their effectors: achieving specificity in membrane traffic. Proc Natl Acad Sci U S A (2006) 6.83
Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev (2011) 5.20
Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes. J Cell Biol (2006) 2.79
Rab GTPases, intracellular traffic and disease. Trends Mol Med (2002) 2.72
Rab27a enables myosin Va-dependent melanosome capture by recruiting the myosin to the organelle. J Cell Sci (2001) 2.09
Removal of osteoclast bone resorption products by transcytosis. Science (1997) 2.08
Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J Cell Biol (2002) 1.93
Trafficking of matrix collagens through bone-resorbing osteoclasts. Science (1997) 1.93
Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86
A small rab GTPase is distributed in cytoplasmic vesicles in non polarized cells but colocalizes with the tight junction marker ZO-1 in polarized epithelial cells. J Cell Biol (1994) 1.80
Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem (2004) 1.78
Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J Bone Miner Res (1991) 1.67
Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts. J Cell Biol (1990) 1.62
The small GTPase Rab13 regulates assembly of functional tight junctions in epithelial cells. Mol Biol Cell (2002) 1.35
Rab8A and Rab13 are activated by insulin and regulate GLUT4 translocation in muscle cells. Proc Natl Acad Sci U S A (2010) 1.35
Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J Biol Chem (2001) 1.33
The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J Cell Sci (1995) 1.33
Rab13 regulates membrane trafficking between TGN and recycling endosomes in polarized epithelial cells. J Cell Biol (2008) 1.30
Organization of osteoclast microfilaments during the attachment to bone surface in vitro. J Bone Miner Res (1989) 1.29
Rab13 regulates PKA signaling during tight junction assembly. J Cell Biol (2004) 1.24
Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay. Calcif Tissue Int (2005) 1.23
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22
In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J Biol Chem (2004) 1.20
Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem (1999) 1.19
Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. J Pathol (2008) 1.17
The small GTPase Rab4A interacts with the central region of cytoplasmic dynein light intermediate chain-1. Biochem Biophys Res Commun (2001) 1.17
Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J Cell Biol (1988) 1.16
Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res (2004) 1.15
Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic (2003) 1.14
Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J Cell Sci (1997) 1.14
Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium. Clin Chem (2000) 1.08
Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol Cell Biol (2005) 1.08
Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J (2000) 1.07
Distinct roles of Rab3B and Rab13 in the polarized transport of apical, basolateral, and tight junctional membrane proteins to the plasma membrane. Biochem Biophys Res Commun (2003) 1.07
Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J (2006) 1.07
Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem (2007) 1.01
Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts. J Biol Chem (2005) 1.01
Regulation of osteoclastic bone resorption by glucose. Biochem Biophys Res Commun (1997) 1.00
Bone-resorbing osteoclasts reveal a dynamic division of basal plasma membrane into two different domains. J Cell Sci (1996) 0.94
A novel method for efficient generation of transfected human osteoclasts. Calcif Tissue Int (2007) 0.94
Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab proteins. Biochem Biophys Res Commun (2002) 0.92
Expression and regulation of RAB3 proteins in osteoclasts and their precursors. J Bone Miner Res (1999) 0.91
Ultrastructural localization of a tartrate-resistant acid ATPase in bone. J Bone Miner Res (1990) 0.89
Identification and characterisation of novel Mss4-binding Rab GTPases. Biol Chem (2011) 0.82
Ultrastructural localization of tartrate-resistant acid phosphatase (purple acid phosphatase) activity in chicken cartilage and bone. Am J Anat (1991) 0.77
Tartrate-resistant bone acid phosphatase: large-scale production and purification of the recombinant enzyme, characterization, and crystallization. J Bone Miner Res (1999) 0.76
Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine. Neuron (2008) 1.96
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer (2002) 1.80
Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. J Clin Endocrinol Metab (2012) 1.49
Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res (2002) 1.46
Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. Mol Pharmacol (2002) 1.38
Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res (2005) 1.36
Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res (2004) 1.28
Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab (2006) 1.22
Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem (2002) 1.22
Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate. J Neurosci (2010) 1.19
PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol Pain (2011) 1.18
Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem (2004) 1.17
Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res (2003) 1.16
Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res (2004) 1.15
Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic (2003) 1.14
The critical role of IL-34 in osteoclastogenesis. PLoS One (2011) 1.14
FGF-8 is involved in bone metastasis of prostate cancer. Int J Cancer (2008) 1.13
Intracellular membrane trafficking in bone resorbing osteoclasts. Microsc Res Tech (2003) 1.13
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res (2005) 1.12
Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res (2007) 1.11
Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem (2004) 1.11
Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption. Biochem Biophys Res Commun (2005) 1.11
Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann N Y Acad Sci (2006) 1.06
Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts. J Biol Chem (2005) 1.01
Bone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 years. J Bone Miner Res (2010) 0.99
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis (2004) 0.98
PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro. Endocrinology (2002) 0.98
Membrane-bound carbonic anhydrases in osteoclasts. Bone (2006) 0.98
Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture. J Bone Miner Res (2006) 0.97
Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix Biol (2005) 0.96
O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. Cancer Res (2007) 0.96
Role of fibroblast growth factor 8 in growth and progression of hormonal cancer. Cytokine Growth Factor Rev (2007) 0.95
The in vitro cytotoxic and apoptotic activity of Triphala--an Indian herbal drug. J Ethnopharmacol (2004) 0.95
Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab (2008) 0.95
Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice. Neoplasia (2010) 0.94
Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem Biophys Res Commun (2003) 0.94
Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. J Neurosci (2013) 0.94
Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer. Prostate (2005) 0.94
Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J Bone Miner Res (2005) 0.93
Biochemical markers of bone turnover are influenced by recently sustained fracture. Bone (2005) 0.93
A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum. J Bone Miner Res (2003) 0.92
Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab proteins. Biochem Biophys Res Commun (2002) 0.92
Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. Endocrinology (2006) 0.92
Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland. J Clin Endocrinol Metab (2004) 0.92
Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur J Endocrinol (2005) 0.91
Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats. Toxicol Appl Pharmacol (2011) 0.91
Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone marrow-derived human mesenchymal stem cells. Tissue Eng Part C Methods (2012) 0.91
Evidence for the role of osteocytes in the initiation of targeted remodeling. Technol Health Care (2009) 0.91
Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice. BMC Cancer (2008) 0.90
Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer (2009) 0.89
RNA interference tolerates 2'-fluoro modifications at the Argonaute2 cleavage site. Chem Biodivers (2007) 0.89
Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding. Biochem Biophys Res Commun (2005) 0.89
Inhibition of the osteoclast V-ATPase by small interfering RNAs. FEBS Lett (2005) 0.88
Phosphatase and oxygen radical-generating activities of mammalian purple acid phosphatase are functionally independent. Biochem Biophys Res Commun (2002) 0.88
The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance. J Bone Miner Res (2003) 0.88
Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. Mol Cell Endocrinol (2008) 0.88
Urinary osteocalcin as a marker of bone metabolism. Clin Chem (2005) 0.88
Potential function for the ROS-generating activity of TRACP. J Bone Miner Res (2003) 0.87
Role of apoptosis, apoptosis-related factors and 17beta-hydroxysteroid dehydrogenases in human corpus luteum regression. Mol Cell Endocrinol (2002) 0.87
Macrophages overexpressing tartrate-resistant acid phosphatase show altered profile of free radical production and enhanced capacity of bacterial killing. Biochem Biophys Res Commun (2005) 0.86
Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro. Bone (2008) 0.86
FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer. J Cell Biochem (2009) 0.86
Cystatin B as an intracellular modulator of bone resorption. Matrix Biol (2006) 0.86
Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1. Matrix Biol (2010) 0.86
A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform. Calcif Tissue Int (2010) 0.86
Pharmacological sequestration of intracellular cholesterol in late endosomes disrupts ruffled border formation in osteoclasts. J Bone Miner Res (2005) 0.86
Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state. J Clin Endocrinol Metab (2003) 0.85
Studies on correlation of antimutagenic and antiproliferative activities of Juglans regia L. J Environ Pathol Toxicol Oncol (2003) 0.85
Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death. Exp Cell Res (2009) 0.84
The architecture of microtubular network and Golgi orientation in osteoclasts--major differences between avian and mammalian species. Exp Cell Res (2003) 0.84
Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition. Breast Cancer Res Treat (2003) 0.83
Inhibition of GGTase-I and FTase disrupts cytoskeletal organization of human PC-3 prostate cancer cells. Cell Biol Int (2010) 0.82
Improved methods for testing antiresorptive compounds in human osteoclast cultures. J Bone Miner Metab (2008) 0.82
Tumor necrosis factor-alpha induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells. Breast Cancer Res Treat (2003) 0.81
Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth. PLoS One (2012) 0.81
Sequence and TLR9 independent increase of TRACP expression by antisense DNA and siRNA molecules. Biochem Biophys Res Commun (2007) 0.81
Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts. BMC Cancer (2010) 0.80
Recombinant VSV G proteins reveal a novel raft-dependent endocytic pathway in resorbing osteoclasts. Exp Cell Res (2008) 0.80
Sex steroid hormone metabolism takes place in human ocular cells. J Steroid Biochem Mol Biol (2003) 0.80
Theoretical investigations of prostatic acid phosphatase. Proteins (2005) 0.80
USF2 is connected to GAAAATATGATA element and associates with androgen receptor-dependent transcriptional regulation in prostate. Prostate (2004) 0.79
Two-photon excitation in fluorescence polarization receptor-ligand binding assay. J Biomol Screen (2005) 0.79
Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphatase. Arch Biochem Biophys (2006) 0.79
Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells. Mol Cell Endocrinol (2006) 0.79
Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine. PLoS One (2012) 0.78
Analysis by siRNA_profile program displays novel thermodynamic characteristics of highly functional siRNA molecules. Source Code Biol Med (2008) 0.78
Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus. J Steroid Biochem Mol Biol (2004) 0.78
Novel perspectives on the transcytotic route in osteoclasts. Bonekey Rep (2013) 0.78
Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium. Biochem Biophys Res Commun (2003) 0.78
Identification of novel proteolytic forms of osteocalcin in human urine. Biochem Biophys Res Commun (2003) 0.77